2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP).
Saved in:
| Title: | 2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP). |
|---|---|
| Authors: | Wunderink, Richard G1 (AUTHOR), Bruno, Christopher2 (AUTHOR), Martin-Loeches, Ignacio3 (AUTHOR), Kollef, Marin4 (AUTHOR), Timsit, Jean-Francois5 (AUTHOR), Yu, Brian2 (AUTHOR), Huntington, Jennifer A2 (AUTHOR), Li, Linping2 (AUTHOR), Jensen, Erin2 (AUTHOR), Wolf, Dominik2 (AUTHOR), Butterton, Joan R2 (AUTHOR), Rhee, Elizabeth G2 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS760-S760. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofz360.1904 |
